AMRITA CENTER FOR NANOSCIENCES AND MOLECULAR MEDICINE BAGS 7 NEW MEDICAL PATENTS
AMRITA CENTER FOR NANOSCIENCES AND MOLECULAR MEDICINE BAGS 7 NEW MEDICAL PATENTS IN C LUDING TREATMENTS FOR MULTIPLE SCLEROSIS AND CANCER AND NEW MEDICAL IMPLANTS AND NAN O CONTRAST AGENTS
Kochi: Amrita Center for Nanoscience and Molecular Medicine at the Kochi Campus of Amrita University has bagged seven national and international patents for its inventions. All seven patents are related to the health se ctor. Three inventions have received American patents and four inventions have received Indian patents, said Dr. Shanti Kumar V. Nair, Director of Amrita Center for Nanoscience and Molecular Medicine and Dean of Research, Amrita Vishwa Vidyapeetham.
The first U.S. patent was granted for a medicine to treat multiple sclerosis, a disease that affects the body’s ne rvous system. This is a comforting discovery for those suffering from Multiple Sclerosis (MS) worldwide.The se cond U.S. patent is for developing the world’s first multimodal nano-contrast agent that can provide improved image resolution in X-rays, MRIs, and infrared fluorescence. It is an effective and innovative discovery for both detection and treatment of cancer.
A third U.S. patent has been obtained for a nanotextile-based small-diameter bl ood vessel graft which lasts lo nger without occlusion during use. It has been su ccessfully tested in rabbits and pigs. The next step will be testi ng in humans.An Indian patent was obtained for the invention of a core-shell nanoparticle system that could de liver multiple drugs simultaneously and target them to the disease efficiently without causing toxicity. Many cancers require multiple drug admin istration which can otherwise be very toxic.
An Indian patent was obtained for the development of a new type of surface-na nostructured orthopaedic and dental implant which integrates very well to sur rounding normal bone. It improves implant life.The last Indian pa tent was obt ained for the invention of a new surface-modified stent that prevents blockage of the vessel after im plant. Current stents elute drugs to prevent blockage but this stent does not require any drugs.
The research behind these discoveries were led by Dr. Shanti Kumar V. Nair, Director of Amrita Center for Nano science and Molecular Medicine, Dr. Manzoor Koyakutty, Dr. Deepthy Menon, Dr Praveen Verma, Dr Krishn aku mar Menon, Dr Gopi Mohan, Dr. Anusha Ashokan, and Dr. Vijay Harish.Amrita Center for Nanoscience and Mole cular Medicine now has a total of 21 patents, out of which 11 are international patents. Also, they have applied for a total of 83 patents.A
